Taiji Yokote
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Taiji Yokote has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Ayami Takayama
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications - Kazuki Iwaki
Department of Internal Medicine (I), Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications M. Tsuji
2 shared publicationsMotomu Tsuji
Division of Surgical Pathology, Osaka Medical College, Osaka, Japan
2 shared publications- Motomu Tsuji
Division of Surgical Pathology, Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka, 569-0801, Japan
2 shared publications S. Hara
2 shared publications
Latest Publications
- Open Access
- 21 November 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 538
A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant
Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemistry with regard to the melanocytic markers HMB45, S100, and Melan-A. However, the translocation t(12; 22)(q13; q12) is specific to CCS. Therefore, although these neoplasms are closely related, they are now considered to be distinct entities. However, the translocation is apparently detectable only in 50%–70% of CCS cases. Therefore, the absence of a detectable EWS/AFT1 rearrangement may occasionally lead to erroneous exclusion of a translocation-negative CCS. Therefore, histological assessment is essential for the correct diagnosis of CCS. Primary CCS of the bone is exceedingly rare. Only a few cases of primary CCS arising in the ulna, metatarsals, ribs, radius, sacrum, and humerus have been reported, and primary CCS arising in the pubic bone has not been reported till date.
- 21 November 2012
- Published by Springer Nature in BMC Cancer
- Vol. 12 (1) , 538
Open AccessA rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant
Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemistry with regard to the melanocytic markers HMB45, S100, and Melan-A. However, the translocation t(12; 22)(q13; q12) is specific to CCS. Therefore, although these neoplasms are closely related, they are now considered to be distinct entities. However, the translocation is apparently detectable only in 50%–70% of CCS cases. Therefore, the absence of a detectable EWS/AFT1 rearrangement may occasionally lead to erroneous exclusion of a translocation-negative CCS. Therefore, histological assessment is essential for the correct diagnosis of CCS. Primary CCS of the bone is exceedingly rare. Only a few cases of primary CCS arising in the ulna, metatarsals, ribs, radius, sacrum, and humerus have been reported, and primary CCS arising in the pubic bone has not been reported till date.
- Open Access
- 28 September 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 131
An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138+ cells
World Health Organization (WHO) criteria are commonly used to diagnose plasma cell myeloma (PCM); however, these criteria are complex and require several laboratory parameters. For differentiating reactive plasmacytosis from clonal plasma cell (PC) neoplasms such as PCM, it is important to accurately determine the expression of cytoplasmic immunoglobulin light chains.
- 28 September 2012
- Published by Springer Nature in Diagnostic Pathology
- Vol. 7 (1) , 131
Open AccessAn approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138+ cells
World Health Organization (WHO) criteria are commonly used to diagnose plasma cell myeloma (PCM); however, these criteria are complex and require several laboratory parameters. For differentiating reactive plasmacytosis from clonal plasma cell (PC) neoplasms such as PCM, it is important to accurately determine the expression of cytoplasmic immunoglobulin light chains.
- 1 September 2006
- Published by Elsevier in Leukemia Research
- Vol. 30 (9) , 1207-1210
Cutaneous infiltration with Waldenström macroglobulinemia
- 1 September 2006
- Published by Elsevier in Leukemia Research
- Vol. 30 (9) , 1207-1210
Cutaneous infiltration with Waldenström macroglobulinemia
- 21 December 2004
- Published by Wiley in European Journal of Haematology
- Vol. 74 (1) , 61-65
Pulmonary parenchymal infiltrates in a patient with CD20‐positive multiple myeloma
Abstract: A 53‐yr‐old woman developed a dry cough after the completion of multi‐agent chemotherapy. The biopsy specimens showed diffuse infiltrates with multiple myeloma (MM) cells. Immunohistochemistry revealed positive staining in MM cells with surface CD20, surface CD38, and cytoplasmic IgG. This report represents the first reported case of pulmonary parenchymal infiltrates in a patient with CD20‐positive MM.
- 21 December 2004
- Published by Wiley in European Journal of Haematology
- Vol. 74 (1) , 61-65
Pulmonary parenchymal infiltrates in a patient with CD20‐positive multiple myeloma
Abstract: A 53‐yr‐old woman developed a dry cough after the completion of multi‐agent chemotherapy. The biopsy specimens showed diffuse infiltrates with multiple myeloma (MM) cells. Immunohistochemistry revealed positive staining in MM cells with surface CD20, surface CD38, and cytoplasmic IgG. This report represents the first reported case of pulmonary parenchymal infiltrates in a patient with CD20‐positive MM.
- Open Access
- 16 January 2004
- Published by Wiley in British Journal of Haematology
- Vol. 125 (1) , 1
Vascular endothelial growth factor and interleukin 6 expression by Hodgkin/Reed‐Sternberg cells
- 16 January 2004
- Published by Wiley in British Journal of Haematology
- Vol. 125 (1) , 1
Open AccessVascular endothelial growth factor and interleukin 6 expression by Hodgkin/Reed‐Sternberg cells
- 28 August 2003
- Published by Springer Nature in Annals of Hematology
- Vol. 83 (1) , 64-66
Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy
Invasive aspergillosis is an important factor in the morbidity and mortality of patients suffering from hematologic disorders treated with chemotherapy. Treatment with amphotericin B is often limited because of toxicity, particularly nephrotoxicity. We describe a case of invasive pulmonary Aspergillus fumigatus infection in acute myeloid leukemia with renal failure due to amphotericin B therapy, which responded to treatment with a new antifungal agent, micafungin. Micafungin appears to be an effective and safe therapy for Aspergillus infections with renal failure due to amphotericin B.
- 28 August 2003
- Published by Springer Nature in Annals of Hematology
- Vol. 83 (1) , 64-66
Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy
Invasive aspergillosis is an important factor in the morbidity and mortality of patients suffering from hematologic disorders treated with chemotherapy. Treatment with amphotericin B is often limited because of toxicity, particularly nephrotoxicity. We describe a case of invasive pulmonary Aspergillus fumigatus infection in acute myeloid leukemia with renal failure due to amphotericin B therapy, which responded to treatment with a new antifungal agent, micafungin. Micafungin appears to be an effective and safe therapy for Aspergillus infections with renal failure due to amphotericin B.